Reference
Sayal K, et al. Epirubicin, cisplatin, and capecitabine for primary platinum-resistant or platinum-refractory epithelial ovarian cancer: Results of a retrospective, single-institution study. International Journal of Gynecological Cancer 25: 977-984, No. 6, Jul 2015. Available from: URL: http://doi.org/10.1097/IGC.0000000000000448 - United Kingdom
Rights and permissions
About this article
Cite this article
Capecitabine/cisplatin/epirubicin. Reactions Weekly 1564, 44 (2015). https://doi.org/10.1007/s40278-015-4187-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-4187-5